Endo caves to FDA pressure, will pull Opana ER from the market
admin 6th July 2017 Uncategorised 0Under pressure from the FDA, Endo has decided to pull from the market its opioid painkiller Opana ER, a drug that generated nearly $160 million in sales last year.
More: Endo caves to FDA pressure, will pull Opana ER from the market
Source: fierce